David H. Mack - Jun 3, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Jun 3, 2021
Transactions value $
$5,300
Form type
4
Date filed
6/4/2021, 07:13 PM
Previous filing
May 24, 2021
Next filing
Jun 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $5.3K +10K +404.86% $0.53* 12.5K May 20, 2021 Direct
holding PMVP Common Stock 228K Jun 3, 2021 See footnote F1
holding PMVP Common Stock 57K Jun 3, 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -10K -2.06% $0.00 475K May 21, 2021 Common Stock 10K $0.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F2 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F3 The shares subject to the option are fully vested and immediately exercisable.